Fetal hemoglobin expression in the compound heterozygous state for -117 (G-->A) Agamma HPFH and IVSII-745 (C-->G) beta+ thalassemia: a case study

Am J Hematol. 1999 Jun;61(2):139-43. doi: 10.1002/(sici)1096-8652(199906)61:2<139::aid-ajh12>3.0.co;2-7.

Abstract

We studied a family in which two inherited defects of the non-alpha-globin cluster segregate: Greek hereditary persistence of fetal hemoglobin (HPFH) and beta-thalassemia. The compound heterozygote is a healthy man with 43% HbF, Ggamma/Agamma ratio (27:73) differing from that of 10 simple heterozygotes for the Greek HPFH (92:8), normal levels of total Hb (13.3 g/dl), and reduced HbA2 levels comparing with the levels of beta-thal heterozygotes for the same mutation. Molecular analysis of the beta-globin genotype revealed the presence of the IVSII-745 (C-->G) beta+ RNA splice mutation in trans with the -117 G-->A Greek HPFH. The beta+ mutation was linked to haplotype VII and the Greek HPFH was associated with haplotype Ia. The father of the compound heterozygote carries the Greek HPFH in trans with the -158 C-->T on the Ggamma promoter, which is linked with haplotype IV. He presented 13.5% HbF with a Ggamma/Agamma ratio 75:25. His daughter was a compound heterozygote for the IVSII-745 mutation in trans with the -158 C-->T, while her HbF levels were 3.7% with a Ggamma/Agamma ratio 31:69.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence / genetics
  • Female
  • Fetal Hemoglobin / genetics*
  • Fetal Hemoglobin / metabolism*
  • Globins / genetics
  • Haplotypes / genetics
  • Heterozygote*
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • RNA Caps
  • RNA Splicing
  • beta-Thalassemia / genetics*

Substances

  • RNA Caps
  • Globins
  • Fetal Hemoglobin